| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,9443 | +4,79% | €1,50B | €157,94K | |
SGRY Surgery Partners, Inc. Common Stock | €11,7786 | +1,38% | €1,50B | €420,96K | |
GAB The Gabelli Equity Trust Inc. | €4,8117 | -0,27% | €1,50B | €550,83K | |
HURN Huron Consulting Group Inc. | €92,4973 | +2,62% | €1,49B | €31,72K | |
ENVX Enovix Corporation Common Stock | €7,1242 | +0,66% | €1,49B | €2,85M | |
PAYO Payoneer Global Inc. Common Stock | €4,4505 | +1,67% | €1,49B | €1,15M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8484 | +0,20% | €1,49B | €97,13K | |
STGW Stagwell Inc. Class A Common Stock | €5,7061 | +0,68% | €1,49B | €343,24K | |
CASH Pathward Financial, Inc. Common Stock | €67,7766 | +1,38% | €1,49B | €61,10K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,3691 | -2,56% | €1,49B | €4,19M | |
STRA Strategic Education, Inc. Common Stock | €69,7675 | +2,63% | €1,49B | €70,98K | |
CAPR Capricor Therapeutics Inc | €24,1832 | +1,74% | €1,49B | €199,67K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,8412 | +3,08% | €1,48B | €1,49K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,6411 | +8,49% | €1,48B | €3,65M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,6500 | +10,04% | €1,48B | €264,69K | |
